Country: Amerika Syarikat
Bahasa: Inggeris
Sumber: NLM (National Library of Medicine)
oxycodone hydrochloride (UNII: C1ENJ2TE6C) (oxycodone - UNII:CD35PMG570)
St Marys Medical Park Pharmacy
oxycodone hydrochloride
oxycodone hydrochloride 20 mg
PRESCRIPTION DRUG
New Drug Application
OXYCONTIN - OXYCODONE HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE ST MARYS MEDICAL PARK PHARMACY ---------- OXYCONTIN (OXYCODONE HCL CONTROLLED-RELEASE) TABLETS CII 10 MG 15 MG 20 MG 30 MG 40 MG 60 MG* 80 MG* 160 MG* * 60 MG, 80 MG, AND 160 MG FOR USE IN OPIOID-TOLERANT PATIENTS ONLY WARNING: OXYCONTIN CONTAINS OXYCODONE WHICH IS AN OPIOID AGONIST AND A SCHEDULE II CONTROLLED SUBSTANCE WITH AN ABUSE LIABILITY SIMILAR TO MORPHINE. OXYCONTIN CAN BE ABUSED IN A MANNER SIMILAR TO OTHER OPIOID AGONISTS, LEGAL OR ILLICIT. THIS SHOULD BE CONSIDERED WHEN PRESCRIBING OR DISPENSING OXYCONTIN IN SITUATIONS WHERE THE PHYSICIAN OR PHARMACIST IS CONCERNED ABOUT AN INCREASED RISK OF MISUSE, ABUSE, OR DIVERS ION. OXYCONTIN TABLETS ARE A CONTROLLED-RELEASE ORAL FORMULATION OF OXYCODONE HYDROCHLORIDE INDICATED FOR THE MANAGEMENT OF MODERATE TO SEVERE PAIN WHEN A CONTINUOUS, AROUND-THE- CLOCK OPIOID ANALGESIC IS NEEDED FOR AN EXTENDED PERIOD OF TIME. OXYCONTIN TABLETS ARE NOT INTENDED FOR USE ON AN AS NEEDED BASIS. PATIENTS CONSIDERED OPIOID TOLERANT ARE THOSE WHO ARE TAKING AT LEAST 60 MG ORAL MORPHINE/DAY, 25 MCG TRANSDERMAL FENTANYL/HOUR, 30 MG ORAL OXYCODONE/DAY, 8 MG ORAL HYDROMORPHONE/DAY, 25 MG ORAL OXYMORPHONE/DAY, OR AN EQUIANALGESIC DOSE OF ANOTHER OPIOID FOR ONE WEEK OR LONGER. OXYCONTIN 60 MG, 80 MG, AND 160 MG TABLETS, A SINGLE DOSE GREATER THAN 40 MG, OR A TOTAL DAILY DOSE GREATER THAN 80 MG ARE ONLY FOR USE IN OPIOID-TOLERANT PATIENTS, AS THEY MAY CAUSE FATAL RESPIRATORY DEPRESSION WHEN ADMINISTERED TO PATIENTS WHO ARE NOT TOLERANT TO THE RESPIRATORY-DEPRESSANT OR SEDATING EFFECTS OF OPIOIDS. PERSONS AT INCREASED RISK FOR OPIOID ABUSE INCLUDE THOSE WITH A PERSONAL OR FAMILY HISTORY OF SUBSTANCE ABUSE (INCLUDING DRUG OR ALCOHOL ABUSE OR ADDICTION) OR MENTAL ILLNESS (E.G., MAJOR DEPRESSION). PATIENTS SHOULD BE ASSESSED FOR THEIR CLINICAL RISKS FOR OPIOID ABUSE OR ADDICTION PRIOR TO BEING PRESCRIBED OPIOIDS. ALL PATIENTS RECEIVING OPIOIDS SHOULD BE ROUTINELY MONITORED FOR SIGNS OF MISUSE, ABUSE AND ADDICTION. OX Baca dokumen lengkap